DK217481A - Fremgangsmaade til fremstilling af pyridoxinderivater eller syreadditionssalte deraf - Google Patents

Fremgangsmaade til fremstilling af pyridoxinderivater eller syreadditionssalte deraf

Info

Publication number
DK217481A
DK217481A DK217481A DK217481A DK217481A DK 217481 A DK217481 A DK 217481A DK 217481 A DK217481 A DK 217481A DK 217481 A DK217481 A DK 217481A DK 217481 A DK217481 A DK 217481A
Authority
DK
Denmark
Prior art keywords
pyridoxin
derivatives
procedure
preparation
acid addition
Prior art date
Application number
DK217481A
Other languages
Danish (da)
English (en)
Inventor
M Descamps
M Urban
Original Assignee
Labaz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Labaz filed Critical Labaz
Publication of DK217481A publication Critical patent/DK217481A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • C07D213/66—One oxygen atom attached in position 3 or 5 having in position 3 an oxygen atom and in each of the positions 4 and 5 a carbon atom bound to an oxygen, sulphur, or nitrogen atom, e.g. pyridoxal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK217481A 1980-05-19 1981-05-18 Fremgangsmaade til fremstilling af pyridoxinderivater eller syreadditionssalte deraf DK217481A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8016516 1980-05-19

Publications (1)

Publication Number Publication Date
DK217481A true DK217481A (da) 1981-11-20

Family

ID=10513518

Family Applications (1)

Application Number Title Priority Date Filing Date
DK217481A DK217481A (da) 1980-05-19 1981-05-18 Fremgangsmaade til fremstilling af pyridoxinderivater eller syreadditionssalte deraf

Country Status (32)

Country Link
US (1) US4374841A (de)
EP (1) EP0040591B1 (de)
JP (1) JPS5711966A (de)
AR (1) AR226356A1 (de)
AT (1) ATE3859T1 (de)
AU (1) AU542463B2 (de)
BG (1) BG35327A3 (de)
CA (1) CA1152080A (de)
CS (1) CS223842B2 (de)
DD (1) DD159071A5 (de)
DE (1) DE3160480D1 (de)
DK (1) DK217481A (de)
EG (1) EG15890A (de)
ES (1) ES8203845A1 (de)
FI (1) FI811525L (de)
GR (1) GR82343B (de)
HU (1) HU183441B (de)
IE (1) IE51179B1 (de)
IL (1) IL62602A (de)
IN (1) IN151915B (de)
IS (1) IS1183B6 (de)
MA (1) MA19147A1 (de)
NO (1) NO811680L (de)
NZ (1) NZ196766A (de)
OA (1) OA06811A (de)
PL (1) PL129213B1 (de)
PT (1) PT72992B (de)
RO (1) RO81943A (de)
SU (1) SU1077566A3 (de)
YU (1) YU126281A (de)
ZA (1) ZA812448B (de)
ZW (1) ZW9681A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4663354A (en) * 1984-04-26 1987-05-05 Klinge Pharma Gmbh Use of etilefrin and etilefrin pivalate in the long term treatment of circulatory disorders not due to hypotonia
DE3519693A1 (de) * 1985-06-01 1987-01-02 Basf Ag Pyridin-derivate, ihre herstellung und verwendung
US6051587A (en) * 1998-04-16 2000-04-18 Medicure, Inc. Treatment of iatrogenic and age-related hypertension and pharmaceutical compositions useful therein
US6043259A (en) * 1998-07-09 2000-03-28 Medicure Inc. Treatment of cardiovascular and related pathologies
ES2250112T3 (es) 1999-03-08 2006-04-16 Medicure Inc. Analogos de piridoxal para el tratamiento de trastornos causados por carencia de vitamina b6.
CA2376029A1 (en) 1999-07-13 2001-01-18 Medicure Inc. Use of pyridoxin derivatives for the treatment of diabetes and related complications
WO2001013900A2 (en) * 1999-08-24 2001-03-01 Medicure International Inc. Compositions for the treatment of cardiovascular diseases containing pyridoxal compounds and cardiovascular compounds
ATE293119T1 (de) 2000-02-29 2005-04-15 Medicure Int Inc Cardioprotektive phosphonate
US7442689B2 (en) * 2000-02-29 2008-10-28 Medicure International Inc. Cardioprotective phosphonates and malonates
AU784840B2 (en) 2000-03-28 2006-07-06 Medicure International Inc. Treatment of cerebrovascular disease
US6548519B1 (en) 2001-07-06 2003-04-15 Medicure International Inc. Pyridoxine and pyridoxal analogues: novel uses
EP1299358B1 (de) 2000-07-07 2007-06-13 Medicure International Inc. Pyridoxin- und pyridoxalanaloga als cardiovasculäre therapeutika
US6897228B2 (en) * 2000-07-07 2005-05-24 Medicure International Inc. Pyridoxine and pyridoxal analogues: new uses
US20040121988A1 (en) * 2001-03-28 2004-06-24 Medicure International Inc. Treatment of cerebrovascular disease
JP4048166B2 (ja) * 2002-11-18 2008-02-13 三井製糖株式会社 血糖値上昇抑制剤及び体脂肪蓄積抑制剤並びに食用材料
US20040186077A1 (en) * 2003-03-17 2004-09-23 Medicure International Inc. Novel heteroaryl phosphonates as cardioprotective agents
AU2004224566A1 (en) * 2003-03-27 2004-10-07 Medicure Inc. Compositions for treating angina
AU2005259735A1 (en) * 2004-07-07 2006-01-12 Medicure International Inc. Combination therapies employing platelet aggregation drugs
US20070060549A1 (en) * 2004-08-10 2007-03-15 Friesen Albert D Combination therapies employing ace inhibitors and uses thereof for the treatment of diabetic disorders
AU2005304220A1 (en) * 2004-10-28 2006-05-18 Medicure International Inc. Dual antiplatelet/anticoagulant pyridoxine analogs
US7459468B2 (en) * 2004-10-28 2008-12-02 Medicure International, Inc. Aryl sulfonic pyridoxines as antiplatelet agents
US20060094749A1 (en) * 2004-10-28 2006-05-04 Medicure International Inc. Substituted pyridoxines as anti-platelet agents
AU2006317440A1 (en) * 2005-11-28 2007-05-31 Medicure International Inc. Selected dosage for the treatment of cardiovascular and related pathologies

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4115575A (en) * 1973-02-20 1978-09-19 Ciba-Geigy Corporation 2-(3-Amino-2-hydroxy-propoxy)-pyrazines
AR206801A1 (es) * 1973-02-20 1976-08-23 Ciba Geigy Ag Procedimiento para la elaboracion de derivados del 1-pirid loxi-2-hidroxi-3-amino-propano
GB1485919A (en) * 1975-08-12 1977-09-14 Grindstedvaerket As Pyridine derivatives
DE2711655A1 (de) * 1977-03-17 1978-09-21 Basf Ag Pyridinyl-aminoalkylaether
US4210653A (en) * 1978-06-27 1980-07-01 Merck & Co., Inc. Pyridyloxypropanolamines

Also Published As

Publication number Publication date
CS223842B2 (en) 1983-11-25
HU183441B (en) 1984-05-28
ATE3859T1 (de) 1983-07-15
ZA812448B (en) 1982-04-28
PL231193A1 (de) 1982-07-05
IS2631A7 (is) 1981-11-11
PT72992B (en) 1982-07-01
YU126281A (en) 1984-02-29
EG15890A (en) 1987-03-30
NO811680L (no) 1981-11-20
US4374841A (en) 1983-02-22
EP0040591B1 (de) 1983-06-22
IL62602A (en) 1984-06-29
NZ196766A (en) 1984-02-03
AU7053581A (en) 1981-11-26
IE51179B1 (en) 1986-10-29
DD159071A5 (de) 1983-02-16
MA19147A1 (fr) 1981-12-31
JPS5711966A (en) 1982-01-21
IN151915B (de) 1983-09-03
IE811085L (en) 1981-11-19
GR82343B (de) 1984-12-13
PL129213B1 (en) 1984-04-30
BG35327A3 (en) 1984-03-15
ES502276A0 (es) 1982-04-01
RO81943B (ro) 1983-05-30
FI811525L (fi) 1981-11-20
DE3160480D1 (en) 1983-07-28
AU542463B2 (en) 1985-02-21
OA06811A (fr) 1982-12-31
EP0040591A1 (de) 1981-11-25
PT72992A (en) 1981-06-01
IL62602A0 (en) 1981-06-29
RO81943A (ro) 1983-06-01
IS1183B6 (is) 1985-05-13
ES8203845A1 (es) 1982-04-01
CA1152080A (en) 1983-08-16
ZW9681A1 (en) 1982-01-20
SU1077566A3 (ru) 1984-02-29
AR226356A1 (es) 1982-06-30

Similar Documents

Publication Publication Date Title
DK217481A (da) Fremgangsmaade til fremstilling af pyridoxinderivater eller syreadditionssalte deraf
DK178379A (da) Fremgangsmaade til fremstilling af n-substituerede moranolinderivater eller syreadditionssalte deraf
DK147362C (da) Analogifremgangsmaade til fremstilling af ergolen- eller ergolin-derivater eller syreadditionssalte deraf
DK162714C (da) Analogifremgangsmaade til fremstilling af glycinamidderivater eller syreadditionssalte deraf
DK56077A (da) Fremgangsmade til fremstilling af 3-quinolincarboxylsyrederivater eller additionssalte deraf
DK77279A (da) Fremgangsmaade til fremstilling af 3-imidazol-1-ylalkyl) indoler eller syreadditionssalte deraf
DK15279A (da) Fremgangsmaade til fremstilling af tetrahydropyridinylindolderivater eller additionssalte deraf
DK145260C (da) Analogifremgangsmaade til fremstilling af 4-acylamino-phenyl-ethanolaminer eller syreadditionssalte heraf
DK157862C (da) Analogifremgangsmaade til fremstilling af imidazolylphenylamidiner eller farmaceutisk acceptable syreadditionssalte deraf
DK413783D0 (da) Fremgangsmade til fremstilling af 20-amino-macrolidderivater eller syreadditionssalte deraf
DK69382A (da) Fremgangsmaade til fremstilling af azepinderivater eller saltederaf
DK163580C (da) Analogifremgangsmaade til fremstilling af cyclohexancarboxylsyrederivater
DK159079A (da) Fremgangsmaade til fremstilling af derivater af 4-amino-2-piperidinoquinazolin eller syreadditionssalte deraf
DK34781A (da) Fremgangsmaade til fremstilling af phenylalkansyrederivater
DK165790C (da) Fremgangsmaade til fremstilling af adriamycin-4'-o-derivater eller syreadditionssalte deraf
DK146066C (da) Analogifremgangsmaade til fremstilling af substituerede 2-phenylimino- imidazolidiner eller syreadditionssalte deraf
DK438482A (da) Fremgangsmaade til fremstilling af indanderivater eller syreadditionssalte deraf
DK491678A (da) Fremgangsmaade til fremstilling af arylaetere af n-alkylpiperidiner eller syreadditionssalte deraf
DK113695A (da) Fremgangsmåde til fremstilling af N-hydroxy-2-azetidinoner eller syreadditionssalte deraf
DK553982A (da) Fremgangsmaade til fremstilling af omt-esterderivater eller syreadditionssalte deraf
DK351880A (da) Fremgangsmaade til fremstilling af tetrahydroquinoliner eller syreadditionssalte deraf
DK172479A (da) Fremgangsmaade til fremstilling af n-alkenylmoranolinderivater eller syreadditionssalte deraf
DK455980A (da) Analogifremgangsmaade til fremstilling af spiroimidazolonforbindelser eller syreaddiionssalte deraf
DK224381A (da) Fremgangsmaade til fremstilling af benzazolderivater eller salte deraf
DK250883A (da) Fremgangsmaade til fremstilling af pyrimidinoner eller deres syreadditionssalte

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment